Standex insider plans Rule 144 sale of 15,000 shares

Standex International Corporation insider filed a notice of proposed stock sales under Rule 144.

Rhea-AI Filing Summary

Standex International Corporation insider filed a notice of proposed stock sales under Rule 144. The filing covers up to 15,000 shares of common stock to be sold through UBS Financial Services on or around 02/17/2026, with an aggregate market value of $3,912,150.00.

The shares relate to restricted stock units that vested on 08/23/2024, when 15,000 common shares were acquired from the issuer. The filing notes that 12,118,733 common shares were outstanding, providing context for the size of the planned sale relative to the company’s equity base.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Standex International (SXI) disclose in this Form 144 filing?

Standex International reports a planned sale of 15,000 common shares under Rule 144. The shares, tied to vested RSUs, have an aggregate market value of $3,912,150.00, indicating a sizable insider-related transaction relative to typical individual stock sales.

How many Standex International (SXI) shares are planned for sale and on what exchange?

The filing covers up to 15,000 Standex International common shares. These shares are expected to be sold on the NYSE, with UBS Financial Services acting as broker, reflecting a structured disposition of previously acquired equity-based compensation.

When were the Standex International (SXI) shares in this Form 144 acquired?

The 15,000 Standex International shares were acquired on 08/23/2024 through an RSU vesting transaction from the issuer. This indicates the planned sale involves stock originally received as equity compensation rather than open-market purchases.

What is the approximate market value of the Standex International (SXI) shares to be sold?

The planned sale of 15,000 Standex International common shares has an aggregate market value of about $3,912,150.00. This figure helps investors gauge the dollar size of the proposed transaction in relation to overall market activity.

How many Standex International (SXI) shares were outstanding according to this Form 144?

The notice states that 12,118,733 Standex International common shares were outstanding. This provides a baseline reference to assess how the proposed 15,000-share sale compares to the company’s overall equity base at the time of the filing.

What trading date does the Standex International (SXI) Form 144 target for the proposed sale?

The filing lists an approximate sale date of 02/17/2026 for the 15,000 Standex International common shares. This date indicates when the broker may begin executing transactions under the Rule 144 notice, subject to market conditions and applicable rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:11 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001595316
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	STANDEX INTERNATIONAL CORP/DE/
SEC File Number	001-07233
Address of Issuer	23 KEEWAYDIN DRIVE SUITE 300 SALEM NEW HAMPSHIRE 03079
Phone	603-893-9701
Name of Person for Whose Account the Securities are To Be Sold	Dunbar David A.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	15000	3912150.00	12118733	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/23/2024	RSU Vest	Issuer			15000	08/23/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares covered under this filing are being sold under The Joana H. Dunbar Irrevocable Trust of 2024.
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for David Dunbar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)